Sector News

Linde buys U.S.-based respiratory therapies specialist

December 7, 2015
Chemical Value Chain

(Reuters) – German industrial gases maker Linde (LING.DE) said on Monday it agreed to acquire U.S.-based respiratory therapies specialist American HomePatient [HIAAMA.UL] from Highland Capital Management LP.

No financial details were disclosed.

The deal is expected to close in the first quarter of 2016.

American HomePatient had sales of about 260 million euros ($282 million) in the last financial year.

($1 = 0.9231 euros)

(Reporting by Christoph Steitz; Editing by James Regan)

comments closed

Related News

May 15, 2022

New York’s EPR and packaging reduction bills lauded as game-changers in plastic pollution battle

Chemical Value Chain

The US State of New York is introducing two new bills to combat over-packaging, poor recycling rates and litter issues, including an Extended Producer Responsibility (EPR) program requiring companies such as McDonald’s and Amazon to pay for the cost of packaging disposal and recycling.

May 15, 2022

Borealis and Reclay launch entity focused on lightweight packaging 

Chemical Value Chain

The new organization’s mission is to redesign the critical steps of the plastics sorting and recycling system for post-consumer lightweight packaging (LWP) to speed up circularity, born from a need to meet the rising market demand for high-quality recyclates for use in high-end plastic applications.

May 15, 2022

Starbucks and Hubbub launch reusable packaging fund as COVID-19 diminishes consumer appetite

Chemical Value Chain

Starbucks and Hubbub have launched a £1 million (US$1.22 million) “Bring It Back Fund” to increase the uptake of reusable packaging in the F&B industry. The funding will go toward innovative ideas that make it easier for customers to use alternatives to single-use packaging by supporting pilot projects that help shift consumption habits.